| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |